BusinessHealthLynked Corp. Announces Retaining the Intellectual Property Law Firm of Lewis Roca Rothgerber Christie LLPBy Nasdaq OMXOct 24, 2017, 9:00 AM UTC
BusinessNewLink Genetics to Host Its Third Quarter 2017 Financial Results Conference Call on November 2, 2017By Nasdaq OMXOct 20, 2017, 12:00 PM UTC
BusinessInca Worldwide (OTC-Pink:QEDN) finished requirements for INVIMA and started negotiations to be the first company inside the duty free Zone in Turbo PISISIBy Nasdaq OMXOct 19, 2017, 1:30 PM UTC
BusinessBioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022By Nasdaq OMXOct 19, 2017, 12:00 PM UTC
BusinessGeneSight® Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine UseBy Nasdaq OMXOct 19, 2017, 11:05 AM UTC
BusinessBioForce Nanosciences Holdings, Inc. (BFNH) Moves Forward With Uplifting Requirements for OTCQB, Aggressively Pursues Take Over TargetsBy Nasdaq OMXOct 18, 2017, 1:15 PM UTC
BusinessGritstone Oncology and Arbutus Biopharma Announce LNP Technology Licensing Agreement to Develop Novel RNA-Based Personalized Neoantigen Immunotherapies for Cancer PatientsBy Nasdaq OMXOct 18, 2017, 12:01 PM UTC
BusinessMyriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Lynparza® (olaparib) in Metastatic Breast CancerBy Nasdaq OMXOct 18, 2017, 11:00 AM UTC